← Back to Search

Offered nicotine replacement therapy for Human Immunodeficiency Virus Infection (QFL Trial)

N/A
Waitlist Available
Led By Lisa Quintiliani, PhD
Research Sponsored by Boston Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks
Awards & highlights

QFL Trial Summary

This trial will test if the Quit for Life program is effective for people with HIV who smoke in China.

Eligible Conditions
  • Human Immunodeficiency Virus Infection
  • Smoking Cessation

QFL Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of Participants With Biochemically Verified Smoking Cessation
Secondary outcome measures
Adherence to Antiretroviral Treatments (ART) at 12 Weeks
Adherence to Antiretroviral Treatments (ART) at 8 Weeks
Change in Number of Cigarettes Smoked in the Previous 30 Days at 12 Weeks
+6 more
Other outcome measures
Intervention Satisfaction at 12 Weeks
Intervention Satisfaction at 8 Weeks

QFL Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Quit for Life groupExperimental Treatment4 Interventions
Participants randomized to this arm will receive a 8 week quit smoking program delivered by trained counselors and messages to their cell phones. Participants will also be offered nicotine replacement therapy (gum or patch, depending on which one is available) and a self-help guide with information about quitting smoking.
Group II: Control groupActive Control2 Interventions
Participants randomized to this arm will be offered nicotine replacement therapy (gum or patch, depending on which one is available) and a self-help guide with information about quitting smoking.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Sessions with a trained counselor
2022
N/A
~110

Find a Location

Who is running the clinical trial?

Boston Medical CenterLead Sponsor
383 Previous Clinical Trials
871,041 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,665 Previous Clinical Trials
40,925,745 Total Patients Enrolled
Lisa Quintiliani, PhDPrincipal InvestigatorBoston Medical Center
2 Previous Clinical Trials
688 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining openings for this experiment?

"As indicated on clinicaltrials.gov, the trial in question is not admitting candidates at this time. This research was initially posted February 24th 2022 and last updated September 2nd 2022. Although recruitment for this study has been paused, there are 621 other studies that are presently enrolling patients."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Quit For Life (QFL): Smoking Cessation Among Chinese Smokers Living With HIV
2022. "Quit For Life (QFL): Smoking Cessation Among Chinese Smokers Living With HIV". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05020899.
~34 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top